Related Experiment Videos
Debridement via collagenase application in two neonates
Ulku Tiras1, Omer Erdeve, Ayse Anil Karabulut
1Department of Pediatrics, Ankara Training and Research Hospital, Ankara, Turkey.
Pediatric Dermatology
|September 30, 2005
Summary
Collagenase clostridipeptidase A effectively debrided wounds in two newborns, offering a less invasive alternative to surgery. This enzymatic eschar removal shows promise for neonates requiring wound treatment.
Area of Science:
- Biochemistry
- Neonatal Medicine
- Wound Healing
Background:
- Slow-healing wounds often lack sufficient collagenase for effective debridement.
- Surgical intervention for necrotic tissue removal in newborns carries significant risks.
Purpose of the Study:
- To evaluate the efficacy of collagenase clostridipeptidase A in wound debridement in neonates.
- To explore enzymatic eschar removal as a safer alternative to surgery in infants.
Main Methods:
- Case report detailing the application of collagenase clostridipeptidase A.
- Treatment of a premature infant with third-degree burns.
- Treatment of a term neonate with calcium gluconate extravasation necrosis.
Main Results:
- Successful wound debridement was achieved in both cases using collagenase clostridipeptidase A.
- Enzymatic treatment avoided surgical complications, anesthesia, and potential blood transfusions.
Conclusions:
- Collagenase clostridipeptidase A is a viable option for enzymatic eschar removal in newborns.
- This enzymatic approach offers a potentially advantageous alternative to surgical debridement in high-risk neonates.